Pharmacopeia Drug Discovery, Inc. incorporated in February
2002, is a biopharmaceutical company, focused on the creation of
small molecule therapeutics to address unmet medical needs. Using
its own technologies and processes, the Company identifies,
optimizes and develops drug candidates in collaboration with
pharmaceutical and biotechnology companies, and through its own
internally funded drug discovery programs. Pharmacopeia's
later-stage portfolio comprises multiple partnered programs that
have been advanced into human clinical trials, with further
programs in late-stage, pre-clinical development. Pharmacopeia
also has approximately 40 partnered and internal programs in
discovery.
Core Technology and Drug Discovery Platform
Pharmacopeia's drug discovery approach is supported by its own
combinatorial chemistry encoding technology. The Company's drug
discovery approach is supported by its own combinatorial chemistry
encoding technology, Encoded Combinatorial Libraries on Polymeric
Support (ECLiPS), its own collection of chemical compounds, assay
technology, production automation, information systems and quality
assurance programs.
Pharmacopeia Drug Discovery Inc.
PO Box 5350
Princeton, NJ 08543-5350
Phone: 609-452-3600
Web Site:
http://www.pharmacopeia.com
